astrazeneca glp 1 pipeline Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework astrazeneca glp 1 pipeline AstraZeneca's

While there is increasing evidence supporting the neuroprotective properties of UA in Parkinsons disease and Alzheimers disease, gaps in knowledge still exist regarding the underlying mechanisms and how to effectively translate these benefits into clinical practice

Lisa Smart, Liberal Democrat MP for Hazel Grove, asked the Secretary of State for Health and Social Care, what steps his department is taking to improve the diagnosis of vitamin B12 deficiency and reduce the number of cases misdiagnosed as (a) dementia, (b) chronic fatigue syndrome, and (c) psychiatric conditions

Pfizer scrapped a different once-daily obesity pill back in June 2023 after patients who took that drug had higher liver enzyme levels in a mid-stage trial

When in doubt, consult qualified healthcare providers familiar with peptide research